PMC:7289100 / 2923-3207 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":73,"end":81},"obj":"Body_part"},{"id":"T10","span":{"begin":271,"end":275},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":4,"end":8},"obj":"Disease"},{"id":"T40","span":{"begin":107,"end":111},"obj":"Disease"},{"id":"T41","span":{"begin":116,"end":160},"obj":"Disease"},{"id":"T42","span":{"begin":126,"end":160},"obj":"Disease"},{"id":"T43","span":{"begin":162,"end":166},"obj":"Disease"},{"id":"T44","span":{"begin":194,"end":202},"obj":"Disease"},{"id":"T45","span":{"begin":194,"end":198},"obj":"Disease"},{"id":"T46","span":{"begin":230,"end":238},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0015542"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0015540"},{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0015542"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T34","span":{"begin":269,"end":275},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":73,"end":98},"obj":"Phenotype"},{"id":"T27","span":{"begin":230,"end":238},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0033041"},{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0001909"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}

{"project":"LitCovid-sentences","denotations":[{"id":"T15","span":{"begin":0,"end":284},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T57","span":{"begin":35,"end":43},"obj":"SP_7"},{"id":"T58","span":{"begin":73,"end":81},"obj":"GO:0019221"},{"id":"T59","span":{"begin":126,"end":140},"obj":"GO:0030097"},{"id":"T60","span":{"begin":194,"end":202},"obj":"SP_10"},{"id":"T61","span":{"begin":207,"end":215},"obj":"SP_9"},{"id":"T62","span":{"begin":269,"end":275},"obj":"CL:0000084"},{"id":"T43778","span":{"begin":35,"end":43},"obj":"SP_7"},{"id":"T76985","span":{"begin":73,"end":81},"obj":"GO:0019221"},{"id":"T80671","span":{"begin":126,"end":140},"obj":"GO:0030097"},{"id":"T49512","span":{"begin":194,"end":202},"obj":"SP_10"},{"id":"T61627","span":{"begin":207,"end":215},"obj":"SP_9"},{"id":"T74273","span":{"begin":269,"end":275},"obj":"CL:0000084"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}

{"project":"LitCovid-PubTator","denotations":[{"id":"82","span":{"begin":180,"end":188},"obj":"Species"},{"id":"83","span":{"begin":194,"end":202},"obj":"Species"},{"id":"84","span":{"begin":207,"end":215},"obj":"Species"},{"id":"85","span":{"begin":239,"end":247},"obj":"Species"},{"id":"102","span":{"begin":4,"end":8},"obj":"Disease"},{"id":"103","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"104","span":{"begin":107,"end":111},"obj":"Disease"},{"id":"105","span":{"begin":116,"end":160},"obj":"Disease"},{"id":"106","span":{"begin":230,"end":238},"obj":"Disease"}],"attributes":[{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"Tax:9606"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"Tax:694009"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"Tax:1335626"},{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Tax:9606"},{"id":"A102","pred":"tao:has_database_id","subj":"102","obj":"MESH:D012128"},{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"MESH:C000657245"},{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"MESH:D012128"},{"id":"A105","pred":"tao:has_database_id","subj":"105","obj":"MESH:D051359"},{"id":"A106","pred":"tao:has_database_id","subj":"106","obj":"MESH:D007938"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as in leukemia patients receiving engineered T cell therapy."}